Loading issues…
- C&T Round Up for April 2022!This week, we highlight the features we published in April! Catch up on what happened at the last Phage Futures Europe, and learn how to organize your phage biobank data!

- C&T Round Up for March 2022!This week, we highlight the features we published in March! Learn about how to name your phage, how to track your phages, and how to get pheedback from phage peers!

- C&T Round Up for February!This week, we highlight the features we published in Feb — learn about digital phagograms, phageSuisse and the recently held Bacteriophage Therapy Summit!

- Let's focus the power of Web3 on science & biotech's problemsPhage Directory started because Jan (a 'tech person') saw how his skills could help fix inefficiencies in Jessica's field: phage biology. Now, more people like Jan are getting excited to focus on solving problems in science/biology/biotech…

- 2022: Building the Operating System for Phage TherapyGood morning, 2022! We’re extremely proud of our work empowering the community, running events like Evergreen and building Instill. This year, we'll be focused on building the “operating system” for phage therapy. From lab workflows to web…

- Reflecting back on 2021It's our last issue of the year! We reflect on what we're especially proud of from this year, and highlight some stats on where we're at as a community!
Also: a giant thanks to each of our amazing volunteers!

- C&T Round Up for November 2021This week, we highlight the feature articles we published in November! Learn about optimizing the route for phage delivery, single use bioreactor technologies vs. traditional solutions, and phage therapy to combat a shell infection in a sea…

- State of Phage #3: Exploring phage collectionsWe're compiling the results of our State of Phage 2020 Survey, and we're excited to show you a third snapshot of the findings! Today we're focusing on phage collections; which phages are labs collecting, how many do they have of each, and…

- Evergreen 2021: Many thanks to all 504 phage phans!Last week, in collaboration with Dr. Betty Kutter and her unstoppable team, we helped run the iconic Evergreen International Phage Meeting — but with a twist — this time it was a hybrid virtual/in-person event! We are overjoyed with how it…

- Raise your impact with Instill ScienceAre your manuscripts meeting their potential? We're launching a new community initiative called Instill Science to help you raise your impact (and get credit for helping your fellow phage community members do the same).

- You're invited to the Evergreen International Phage Meeting!In case you haven't heard, the Evergreen Phage Meeting is happening both in person and online this year in Olympia, Washington from Aug 1-6. This week, we're highlighting what to expect from this meeting (via a letter from Betty Kutter) and…

- C&T Round Up for May 2021This week, we're highlighting the three feature articles we published in May: a 'behind-the-paper' guest post by Steven Sutcliffe and Michael Shamash, a full recap of all six iVoM webinars by Ivone Martins and Luis Melo, and an interview…

- C&T Round Up for April 2021This week, we're highlighting the four feature articles we published in April: virtual event recaps by volunteers Rohit Kongari and Stephanie Lynch, a guide on responding to phage therapy requests, and an opinion piece by Mert Selimoglu on…

- How to respond when someone asks you for phage therapyAre you getting phage therapy requests from the public, and wondering how to respond? We've put together a guide + resources you can use (short version: send them our way)!
Bonus: we've included resources for physicians too, including how…

- Phage Futures Congress 2021: Meeting RecapWe attended Kisaco Research's Phage Futures Congress 2021 at the end of February, and now present our recap of the event. We hope to provide a window into what you missed, and/or a refresher if you were there!

- Quick Dive: Diabetic foot ulcers and phage therapyToday we're doing a quick dive into diabetic foot ulcers and phages. What's the problem, what are some ways phages have been used to date, and what's the current status of clinical trials?

- C&T Round Up for February 2021This week, we're highlighting the four feature articles we published in February: an interview with Richard Alm of CARB-X, part two of our State of Phage survey results, and a recap of the three phage events we hosted last week, written by…

- State of Phage #2: A wide diversity of strainsWe're compiling the results of our State of Phage 2020 Survey, and we're excited to show you a second snapshot of the findings! Today we're focusing on strain collections; which bacterial species are phage labs collecting, how many do they…

- Funding phage development — a Q&A with CARB-X's Richard AlmThis week, we bring you an interview with Dr. Richard Alm, Alliance Director at CARB-X, a major current funder of new antimicrobials, including phage! Richard shares how he sees phages fitting into the clinical landscape, and shares his…

- State of Phage #1: A wide diversity of backgrounds & phage experienceIt's been almost three months since we launched our State of Phage 2020 Survey! We're excited to show you a snapshot of the data coming in. Today we're focusing on who responded to the survey: where are they from, what's their career stage,…

